RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M Turnover 25%
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-24.74%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$512M
AUM Growth
-$138M
Cap. Flow
+$27.1M
Cap. Flow %
5.29%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
OKUR icon
OnKure Therapeutics
OKUR
+$26.9M
2
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$206K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ALLK icon
1
DELISTED
Allakos
ALLK
$417M 81.57%
4,887,932
– –
2020 Q4
2 quarters
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$5.19B
$33.2M 6.49%
1,921,118
– –
2020 Q4
2 quarters
SPRB icon
3
Spruce Biosciences
SPRB
$112M
$24.1M 4.71%
28,644
– –
2020 Q4
2 quarters
OKUR icon
4
OnKure Therapeutics
OKUR
$91.1M
$22.5M 4.39%
+240,922
New +$26.9M
2021 Q2
0 quarters
VAPO
5
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$14.5M 2.84%
76,828
+1,206
+2% +$206K
2020 Q4
2 quarters

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q2 2021 Portfolio in Review

As of Q2 2021, RiverVest Venture Management held 5 positions worth $512M, down 21% from $649M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management deployed $27.1M of net new capital in Q2 2021, opening 1 new position and adding to 1 existing holding. Its largest new stake was OnKure Therapeutics: 240,922 shares worth $22.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's largest Q2 2021 buy was OnKure Therapeutics: 240,922 shares worth $22.5M.
  • RiverVest Venture Management added most to Vapotherm, Inc. Common Stock in Q2 2021, an estimated $206K increase.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $512M portfolio in Q2 2021.
  • RiverVest Venture Management opened 1 new position and closed 0 in Q2 2021.
  • RiverVest Venture Management's portfolio value fell 21% quarter-over-quarter to $512M.

Based on RiverVest Venture Management's 13F filing for Q2 2021, filed 11 Aug 2021.